Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients

被引:77
作者
Lee, Seung-Hwan [2 ]
Park, Shin-Ae [2 ]
Ko, Seung-Hyun [2 ]
Yim, Hyeon-Woo [3 ]
Ahn, Yu-Bae [2 ]
Yoon, Kun-Ho [1 ]
Cha, Bong-Yun [1 ]
Son, Ho-Young [1 ]
Kwon, Hyuk-Sang [1 ]
机构
[1] Catholic Univ Korea, Dept Internal Med, Kangnam St Marys Hosp, Div Endocrinol & Metab, Seoul 137701, South Korea
[2] Catholic Univ Korea, St Vincents Hosp, Dept Internal Med, Div Endocrinol & Metab, Suwon 442723, South Korea
[3] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul 137701, South Korea
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2010年 / 59卷 / 02期
关键词
CHRONIC KIDNEY-DISEASE; RENAL-FUNCTION; RISK-FACTORS; MARKER; DEATH; HEART; CREATININE; EVENTS; GFR; ATHEROSCLEROSIS;
D O I
10.1016/j.metabol.2009.07.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies suggest that serum cystatin C level is not only a sensitive marker for renal dysfunction but also a predictive marker for cardiovascular disease (CVD) However, the mechanism of this connection is not fully understood We aimed to determine whether insulin resistance or various biomarkers of cardiovascular risk have a role in the link between cystatin C and CVD in type 2 diabetes mellitus patients. Anthropometric measurements and biochemical studies including inflammatory biomarkers were performed in 478 patients with type 2 diabetes mellitus The degree of insulin resistance was assessed by homeostasis model assessment (HOMA-IR) and indicators of metabolic syndrome Estimated glomerulai filtration rate (eGER) was derived from the Modification of Diet in Renal Disease study equation After adjusting for age, sex, body mass index, and eGER, the cystatin C level increased significantly in proportion to the number of metabolic syndrome components present (1.08 +/- 0.06, 1.19 +/- 0.04, 1.20 +/- 0.04, 1.23 +/- 0.04, and 1.37 +/- 0.06 mg/L, P < 0001), and HOMA-IR increased significantly in proportion to cystatm C quartiles (I 16 0 15, 1 40 0 13, I 49 (1 13, and 2 00 0 17, P < 0001) (means SE) Albumn-creatinine ratio. fibrinogen, uric acid. homocysteine, high-sensitivity C-reactive protein, and lipoprotein(a) all showed significant correlations with cystatm C that were generally higher than those with eGFR Cystatin C level was independently associated with HOMA-IR (beta = 0.0380, P = 0082), albumin-mainline ratio (beta = 0.0004, P < 0001), uric acid (beta = 0.0666, P < .0001), and homocysteme (beta = 0 0087, P = 0004) In conclusion, cystatm C level was significantly associated with insulin resistance and biomarkers reflecting inflammation independent of renal function These components may have a role in addition to that of eGER in explaining the link between cystatm C and CVD in type 2 diabetes mellitus patients (C) 2010 Elsevier Inc All rights reserved.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 32 条
[1]   Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database [J].
Bonora, Enzo ;
Capaldo, Brunella ;
Perin, Paolo Cavallo ;
Del Prato, Stefano ;
De Mattia, Giancarlo ;
Frittitta, Lucia ;
Frontoni, Simona ;
Leonetti, Frida ;
Luzi, Livio ;
Marchesini, Giulio ;
Marini, Maria Adelaide ;
Natali, Andrea ;
Paolisso, Giuseppe ;
Piatti, Pier Marco ;
Pujia, Arturo ;
Solini, Anna ;
Vettor, Roberto ;
Bonadonna, Riccardo C. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (09) :624-631
[2]   Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis [J].
Dharnidharka, VR ;
Kwon, C ;
Stevens, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) :221-226
[3]   Elevated cystatin C concentration and progression to pre-diabetes [J].
Donahue, Richard P. ;
Stranges, Saverio ;
Rejman, Karol ;
Rafalson, Lisa B. ;
Dmochowski, Jacek ;
Trevisan, Maurizio .
DIABETES CARE, 2007, 30 (07) :1724-1729
[4]   Cystatin C as a marker of GFR -: history, indications, and future research [J].
Filler, G ;
Bökenkamp, A ;
Hofmann, W ;
Le Bricon, T ;
Martínez-Brú, C ;
Grubb, A .
CLINICAL BIOCHEMISTRY, 2005, 38 (01) :1-8
[5]   Determination of serum cystatin C: Biological variation and reference values [J].
Galteau, MM ;
Guyon, M ;
Gueguen, R ;
Siest, G .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (09) :850-857
[6]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305
[7]   Cystatin C - A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome [J].
Jernberg, T ;
Lindahl, B ;
James, S ;
Larsson, A ;
Hansson, LO ;
Wallentin, L .
CIRCULATION, 2004, 110 (16) :2342-2348
[8]   Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: A cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA) [J].
Keller, Christopher ;
Katz, Ronit ;
Cushman, Mary ;
Fried, Linda F. ;
Shlipak, Michael .
BMC NEPHROLOGY, 2008, 9 (1)
[9]   Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement [J].
Knight, EL ;
Verhave, JC ;
Spiegelman, D ;
Hillege, HL ;
De Zeeuw, D ;
Curhan, GC ;
De Jong, PE .
KIDNEY INTERNATIONAL, 2004, 65 (04) :1416-1421
[10]   Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate [J].
Koenig, W ;
Twardella, D ;
Brenner, H ;
Rothenbacher, D .
CLINICAL CHEMISTRY, 2005, 51 (02) :321-327